Smith & Nephew plc (LON:SN) Insider Acquires £41,948.10 in Stock

Smith & Nephew plc (LON:SN) insider Sybella Stanley purchased 3,810 shares of the stock in a transaction dated Wednesday, March 26th. The shares were acquired at an average cost of GBX 1,101 ($14.18) per share, with a total value of £41,948.10 ($54,008.11).

Smith & Nephew Stock Up 1.3 %

LON SN opened at GBX 1,093.50 ($14.08) on Thursday. The company has a quick ratio of 0.84, a current ratio of 2.51 and a debt-to-equity ratio of 70.22. The company’s fifty day moving average price is GBX 1,067.41 and its 200-day moving average price is GBX 1,053.16. The stock has a market capitalization of £11.99 billion, a P/E ratio of 39.37, a price-to-earnings-growth ratio of 0.46 and a beta of 0.62.

Smith & Nephew Increases Dividend

The business also recently declared a dividend, which will be paid on Wednesday, May 28th. Investors of record on Thursday, March 27th will be paid a $0.23 dividend. This is an increase from Smith & Nephew’s previous dividend of $0.14. This represents a yield of 1.61%. The ex-dividend date is Thursday, March 27th. Smith & Nephew’s dividend payout ratio is presently 104.41%.

Analysts Set New Price Targets

Separately, JPMorgan Chase & Co. restated an “overweight” rating and set a GBX 1,180 ($15.19) price objective on shares of Smith & Nephew in a research report on Tuesday, January 14th.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.